Web Results

BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC ...

search.rpxcorp.com/lit/njdce-323095-boehringer-ingelheim-pharmaceuticals-v-hec-pharm

BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO. , LTD. et al. 3:15-cv-05982; Filed: 08/04/2015; Case Updated Daily; Latest ...

Boehringer Ingelheim Pharmaceuticals, Inc. | Federal Trade ...

www.ftc.gov/enforcement/cases-proceedings/091-0023/boehringer-ingelheim-pharmaceuticals-inc

Feb 20, 2015 ... application/pdf icon FTC v. Boehringer Ingelheim Pharmaceuticals, Inc. (D.C. Cir. ), Response of FTC to Petition for Rehearing En Banc (113.12 ...

TOROSYAN v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC

www.leagle.com/decision/1995235234Conn1_1235/TOROSYAN v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

234 Conn. 1 (1995). ANUSHAVAN G. TOROSYAN v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. Supreme Court of Connecticut. Argued March 21 ...

View Paper

mfprac.com/web2016/06diseases/endocrine/dm/Buse_Liraglutide.pdf

Jun 8, 2009 ... exenatide (1.93 vs 2.60 events per patient .... Pharmaceuticals Inc, San Diego, CA, USA), and ..... Henriksen, K Hermansen, S Hippler, J ... fonsultant for Boehringer- Ingelheim ... Nathan DM, Buse JB, Davidson MB, et al.

ISPOR 19th Annual International Meeting - Poster Presentations

www.ispor.org/event/ProgramList/2014Montreal?type=Poster&sess=II&acode=PCV

EFFECT OF PRASUGREL VS CLOPIDOGREL ON HOSPITAL READMISSION ..... QC, Canada, <sup>2</sup>Institut national d'excellence en santé et services sociaux, Montreal, QC, .... <sup>1</sup>University of Utah, Salt Lake City, UT, USA, <sup>2</sup>Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA ..... Asche C<sup>1</sup>, Ren J<sup>1</sup>, Hippler SE<sup>2</sup>

Quality of anticoagulation with warfarin in patients with ... - DUCCS

dukeduccs.org/wp-content/uploads/2015/02/BI-TTR-paper_Heitner-J-Electro-46-2013.pdf

vs cardiology practices was 55.3% vs. .... 56.7%. Cios et al.23 and Baker et al.24 found similar results .... Boehringer Ingelheim Pharmaceuticals, Inc. There are no patents, products in ... Clemson, MD, Stephen Hippler, MD, Bill Carter, MD, and.

Reference Guide on Survey Research - Federal Judicial Center

www.fjc.gov/public/pdf.nsf/lookup/sciman04.pdf/$file/sciman04.pdf

employees currently working for a corporation, all trees in a forest), sample ..... F. King, Statistics in Antitrust Litigation, in Statistics and the Law 49 (Morris H. DeGroot et al. eds., .... E.g., Boehringer Ingelheim G.m.b.H. v. ...... Norbert Schwarz & Hans-Jürgen Hippler, Response Alternatives: The Impact of Their Choice and...

More Info

BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. DR ...

search.rpxcorp.com

BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. DR. REDDY'S LABORATORIES, LTD. et al. 3:16-cv-02394; Filed: 04/28/2016; Closed: 05/16/ ...

Qualcomm and Boehringer Ingelheim Pharmaceuticals collaborate ...

us.boehringer-ingelheim.com

Aug 30, 2016 ... SAN DIEGO, CALIFORNIA and Ridgefield, Connecticut— August 30, 2016 — Boehringer Ingelheim Pharmaceuticals Inc. and Qualcomm ...

Perioperative treatment options in resectable pancreatic cancer - NCBI

www.ncbi.nlm.nih.gov

Mar 15, 2016 ... An analysis by Birkmeyer et al[7] showed absolute differences in 5-year survival ..... Bristol Myers Squipp, Boehringer Ingelheim, Daiichi-Sankyo, Leo Pharma, .... Kamphues C, Bova R, Schricke D, Hippler-Benscheidt M, Klauschen F, ... Adjuvant chemotherapy with gemcitabine vs observation in patients ...